Basic Information
Basic information for FTX-202-18aa-2
Peptide Name FTX-202-18aa-2
Genome Position chrX:74203188-74203241[-]
Species Human
Peptide Sequence MLEAAPDALSIFFPLILS
Peptide Length 18
Unique No (FTX-210-18aa-2,FTX-218-18aa,FTX-223-18aa-1,FTX-224-18aa,FTX-228-18aa-1,FTX-229-18aa-2,FTX-231-18aa-2,FTX-233-18aa-1,FTX-236-18aa-1,FTX-238-18aa-1,FTX-241-18aa-2,FTX-245-18aa-2,FTX-257-18aa-1,FTX-261-18aa-2,FTX-264-18aa-2,FTX-265-18aa-2,FTX-266-18aa-1,FTX-268-18aa-2)
Grand Average of Hydropathicity 1.4056
Relative Molecular Mass 2254.55
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000423992;FTX-202
Transcript Length 1997
Coding Ability 0.5914
DNA Sequence Corresponding to Peptide ATGTTGGAGGCAGCACCTGATGCACTATCCATATTCTTCCCCTTGATCTTGTCT
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :